脂质体米托蒽酮克服获得性耐药性并增强Venetoclax协同作用在急性髓系白血病中的应用——机制探讨及初步临床证据
Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence
Kunpeng Luo, Yan Hui, Heng Shen, Lin Yan, Yu Zeng, Luyao Zhou, Min Wang, Jianxiang Wang, Mingcheng Liu, Hui Wei
Journal:International Journal of Nanomedicine
IF:8.7
DOI:10.2147/IJN.S634276
PMID:
Published:2026-09-21
research field:肿瘤学白血病治疗转化医学药物递送系统血液病学单细胞组学
Abstract
Introduction Liposomal drug delivery has emerged as a promising strategy to improve the efficacy and safety of chemotherapeutic agents, yet whether and how liposomal reformulation fundamentally reshapes therapeutic response and resistance evolution remains unclear. This study compared liposomal mitoxantrone with free mitoxantrone and examined their effects on antileukemic activity, hematologic toxicity, resistance development, and cell-death pathways.Methods Liposomal and free mitoxantrone were evaluated in an MLL-AF9–driven acute myeloid leukemia mouse model by survival analysis and peripheral blood measurements. Secondary transplantation experiments were performed to evaluate the sensitivity of residual leukemia cells. Single-cell RNA sequencing was used to characterize transcriptional features of residual leukemia cells. Drug combination with venetoclax and the cell killing pattern of the two drugs were explored based on MOLM13 cell line. Exploratory clinical observations were additionally obtained from four patients who received liposomal mitoxantrone in combination with venetoclax.Results Liposomal mitoxantrone significantly prolonged mouse survival compared with free-mitoxantrone and control groups (both p < 0.001), while causing minimal myelosuppression. In contrast, free-mitoxantrone induced marked hematologic toxicity. Secondary transplantation demonstrated that residual cells following free-mitoxantrone treatment developed resistance upon re-exposure (p < 0.001), while those from liposomal-treated mice retained drug sensitivity and conferred sustained survival benefit (both p < 0.01). Single-cell RNA sequencing revealed that free-mitoxantrone induced transcriptional heterogeneity, characterized by enhanced metabolic and immune-related pathways, and monocyte-like features, whereas liposomal-mitoxantrone preserved a proliferative state similar to untreated cells. Consistently, liposomal-mitoxantrone demonstrated stronger synergistic effects with venetoclax.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


